Strategic partnerships Leverage LenioBio collaboration and the Complex Genes launch to expand co-developed workflows, offering integrated DNA synthesis with cell-free expression and gene assembly services to accelerate client prototypes.

Growth segments DSPS and NGS revenue strength with expanding gross margin indicates sustained demand for scalable DNA synthesis and sequencing services; target labs seeking end-to-end solutions, including oligo pools and target enrichment.

Competitive edge Twist's silicon-based manufacturing offers high-throughput, cost-effective DNA synthesis; tailor messaging to customers comparing to IDT, GenScript, and Eurofins Genomics; propose faster turnaround, custom scale, and quality.

Market expansion Position Twist to serve life science researchers across medicine, agriculture, and industrial chemicals; pursue enterprise deals with biotech institutes, pharma, and ag-tech firms seeking rapid, precise gene constructs and libraries.

Global scale Strong funding and workforce readiness enable global expansion; explore regional partnerships, U.S./Europe/Asia presence, and channel partnerships to broaden reach with universities, contract labs, and biotechs.